What are the responsibilities and job description for the Senior Clinical Data Coordinator position at IQVIA?
Location: Home-based
Job summary: Join a sponsor-dedicated CDM team to make an immediate impact on study success for a Biopharma company – working fully within the sponsor environment. The Senior Clinical Data Coordinator performs activities for Phase I, II and III clinical trials in accordance with ICH/Good Clinical Practices (GCP) and other relevant procedures and guidelines. The Senior Clinical Data Coordinator helps to ensure that a quality work product is produced and timelines/deliverables are met.
Key Responsibilities:
Perform ongoing data review including reconciliation of third-party data streams and serious adverse event reconciliation with the safety database.
Perform User Acceptance Testing (UAT) of clinical databases.
Perform Quality Control (QC) of clinical databases.
Perform ongoing updates of documentation related to data management.
Qualifications:
Bachelor’s degree or certification in a related health profession from accredited institution.
4 years or more of clinical data management experience.
Experience with Electronic Data Capture (EDC) systems is required.
Experience with Oracle Inform EDC system is preferred.
Oncology or Inflammatory therapeutic experience is preferred.
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. We believe in pushing the boundaries of human science and data science to make the biggest impact possible – to help our customers create a healthier world. Learn more at https://jobs.iqvia.com
We are committed to providing equal employment opportunities for all, including veterans and candidates with disabilities. https://jobs.iqvia.com/eoe
As the COVID-19 virus continues to evolve, IQVIA’s ability to operate and provide certain services to customers and partners necessitates IQVIA and its employees meet specific requirements regarding vaccination status. https://jobs.iqvia.com/covid-19-vaccine-status